Global Cardiology Radiopharmaceuticals Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Description

According to our (Global Info Research) latest study, the global Cardiology Radiopharmaceuticals market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period.

The Global Info Research report includes an overview of the development of the Cardiology Radiopharmaceuticals industry chain, the market status of Therapeutic Use (Technetium-99, Fluorine-18), Diagnostic Use (Technetium-99, Fluorine-18), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Cardiology Radiopharmaceuticals.

Regionally, the report analyzes the Cardiology Radiopharmaceuticals markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Cardiology Radiopharmaceuticals market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the Cardiology Radiopharmaceuticals market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Cardiology Radiopharmaceuticals industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Technetium-99, Fluorine-18).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Cardiology Radiopharmaceuticals market.

Regional Analysis: The report involves examining the Cardiology Radiopharmaceuticals market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Cardiology Radiopharmaceuticals market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Cardiology Radiopharmaceuticals:
Company Analysis: Report covers individual Cardiology Radiopharmaceuticals players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Cardiology Radiopharmaceuticals This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Therapeutic Use, Diagnostic Use).

Technology Analysis: Report covers specific technologies relevant to Cardiology Radiopharmaceuticals. It assesses the current state, advancements, and potential future developments in Cardiology Radiopharmaceuticals areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Cardiology Radiopharmaceuticals market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
Cardiology Radiopharmaceuticals market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.

Market segment by Type
    Technetium-99
    Fluorine-18
    Gallium-67
    Others

Market segment by Application
    Therapeutic Use
    Diagnostic Use

Market segment by players, this report covers
    GE Healthcare
    Cardinal Health
    Curium Pharma
    Lantheus Medical Imaging, Inc.
    Eczacıbaşı Monrol Nuclear Products
    Novartis International AG
    Siemens
    China Isotope & Radiation
    Yantai Dongcheng Pharmaceutical
    Jubilant Life Sciences
    Bracco

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Cardiology Radiopharmaceuticals product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Cardiology Radiopharmaceuticals, with revenue, gross margin and global market share of Cardiology Radiopharmaceuticals from 2018 to 2023.
Chapter 3, the Cardiology Radiopharmaceuticals competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Cardiology Radiopharmaceuticals market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Cardiology Radiopharmaceuticals.
Chapter 13, to describe Cardiology Radiopharmaceuticals research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Cardiology Radiopharmaceuticals
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of Cardiology Radiopharmaceuticals by Type
        1.3.1 Overview: Global Cardiology Radiopharmaceuticals Market Size by Type: 2018 Versus 2022 Versus 2029
        1.3.2 Global Cardiology Radiopharmaceuticals Consumption Value Market Share by Type in 2022
        1.3.3 Technetium-99
        1.3.4 Fluorine-18
        1.3.5 Gallium-67
        1.3.6 Others
    1.4 Global Cardiology Radiopharmaceuticals Market by Application
        1.4.1 Overview: Global Cardiology Radiopharmaceuticals Market Size by Application: 2018 Versus 2022 Versus 2029
        1.4.2 Therapeutic Use
        1.4.3 Diagnostic Use
    1.5 Global Cardiology Radiopharmaceuticals Market Size & Forecast
    1.6 Global Cardiology Radiopharmaceuticals Market Size and Forecast by Region
        1.6.1 Global Cardiology Radiopharmaceuticals Market Size by Region: 2018 VS 2022 VS 2029
        1.6.2 Global Cardiology Radiopharmaceuticals Market Size by Region, (2018-2029)
        1.6.3 North America Cardiology Radiopharmaceuticals Market Size and Prospect (2018-2029)
        1.6.4 Europe Cardiology Radiopharmaceuticals Market Size and Prospect (2018-2029)
        1.6.5 Asia-Pacific Cardiology Radiopharmaceuticals Market Size and Prospect (2018-2029)
        1.6.6 South America Cardiology Radiopharmaceuticals Market Size and Prospect (2018-2029)
        1.6.7 Middle East and Africa Cardiology Radiopharmaceuticals Market Size and Prospect (2018-2029)

2 Company Profiles
    2.1 GE Healthcare
        2.1.1 GE Healthcare Details
        2.1.2 GE Healthcare Major Business
        2.1.3 GE Healthcare Cardiology Radiopharmaceuticals Product and Solutions
        2.1.4 GE Healthcare Cardiology Radiopharmaceuticals Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 GE Healthcare Recent Developments and Future Plans
    2.2 Cardinal Health
        2.2.1 Cardinal Health Details
        2.2.2 Cardinal Health Major Business
        2.2.3 Cardinal Health Cardiology Radiopharmaceuticals Product and Solutions
        2.2.4 Cardinal Health Cardiology Radiopharmaceuticals Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 Cardinal Health Recent Developments and Future Plans
    2.3 Curium Pharma
        2.3.1 Curium Pharma Details
        2.3.2 Curium Pharma Major Business
        2.3.3 Curium Pharma Cardiology Radiopharmaceuticals Product and Solutions
        2.3.4 Curium Pharma Cardiology Radiopharmaceuticals Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 Curium Pharma Recent Developments and Future Plans
    2.4 Lantheus Medical Imaging, Inc.
        2.4.1 Lantheus Medical Imaging, Inc. Details
        2.4.2 Lantheus Medical Imaging, Inc. Major Business
        2.4.3 Lantheus Medical Imaging, Inc. Cardiology Radiopharmaceuticals Product and Solutions
        2.4.4 Lantheus Medical Imaging, Inc. Cardiology Radiopharmaceuticals Revenue, Gross Margin and Market Share (2018-2023)
        2.4.5 Lantheus Medical Imaging, Inc. Recent Developments and Future Plans
    2.5 Eczacıbaşı Monrol Nuclear Products
        2.5.1 Eczacıbaşı Monrol Nuclear Products Details
        2.5.2 Eczacıbaşı Monrol Nuclear Products Major Business
        2.5.3 Eczacıbaşı Monrol Nuclear Products Cardiology Radiopharmaceuticals Product and Solutions
        2.5.4 Eczacıbaşı Monrol Nuclear Products Cardiology Radiopharmaceuticals Revenue, Gross Margin and Market Share (2018-2023)
        2.5.5 Eczacıbaşı Monrol Nuclear Products Recent Developments and Future Plans
    2.6 Novartis International AG
        2.6.1 Novartis International AG Details
        2.6.2 Novartis International AG Major Business
        2.6.3 Novartis International AG Cardiology Radiopharmaceuticals Product and Solutions
        2.6.4 Novartis International AG Cardiology Radiopharmaceuticals Revenue, Gross Margin and Market Share (2018-2023)
        2.6.5 Novartis International AG Recent Developments and Future Plans
    2.7 Siemens
        2.7.1 Siemens Details
        2.7.2 Siemens Major Business
        2.7.3 Siemens Cardiology Radiopharmaceuticals Product and Solutions
        2.7.4 Siemens Cardiology Radiopharmaceuticals Revenue, Gross Margin and Market Share (2018-2023)
        2.7.5 Siemens Recent Developments and Future Plans
    2.8 China Isotope & Radiation
        2.8.1 China Isotope & Radiation Details
        2.8.2 China Isotope & Radiation Major Business
        2.8.3 China Isotope & Radiation Cardiology Radiopharmaceuticals Product and Solutions
        2.8.4 China Isotope & Radiation Cardiology Radiopharmaceuticals Revenue, Gross Margin and Market Share (2018-2023)
        2.8.5 China Isotope & Radiation Recent Developments and Future Plans
    2.9 Yantai Dongcheng Pharmaceutical
        2.9.1 Yantai Dongcheng Pharmaceutical Details
        2.9.2 Yantai Dongcheng Pharmaceutical Major Business
        2.9.3 Yantai Dongcheng Pharmaceutical Cardiology Radiopharmaceuticals Product and Solutions
        2.9.4 Yantai Dongcheng Pharmaceutical Cardiology Radiopharmaceuticals Revenue, Gross Margin and Market Share (2018-2023)
        2.9.5 Yantai Dongcheng Pharmaceutical Recent Developments and Future Plans
    2.10 Jubilant Life Sciences
        2.10.1 Jubilant Life Sciences Details
        2.10.2 Jubilant Life Sciences Major Business
        2.10.3 Jubilant Life Sciences Cardiology Radiopharmaceuticals Product and Solutions
        2.10.4 Jubilant Life Sciences Cardiology Radiopharmaceuticals Revenue, Gross Margin and Market Share (2018-2023)
        2.10.5 Jubilant Life Sciences Recent Developments and Future Plans
    2.11 Bracco
        2.11.1 Bracco Details
        2.11.2 Bracco Major Business
        2.11.3 Bracco Cardiology Radiopharmaceuticals Product and Solutions
        2.11.4 Bracco Cardiology Radiopharmaceuticals Revenue, Gross Margin and Market Share (2018-2023)
        2.11.5 Bracco Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Cardiology Radiopharmaceuticals Revenue and Share by Players (2018-2023)
    3.2 Market Share Analysis (2022)
        3.2.1 Market Share of Cardiology Radiopharmaceuticals by Company Revenue
        3.2.2 Top 3 Cardiology Radiopharmaceuticals Players Market Share in 2022
        3.2.3 Top 6 Cardiology Radiopharmaceuticals Players Market Share in 2022
    3.3 Cardiology Radiopharmaceuticals Market: Overall Company Footprint Analysis
        3.3.1 Cardiology Radiopharmaceuticals Market: Region Footprint
        3.3.2 Cardiology Radiopharmaceuticals Market: Company Product Type Footprint
        3.3.3 Cardiology Radiopharmaceuticals Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global Cardiology Radiopharmaceuticals Consumption Value and Market Share by Type (2018-2023)
    4.2 Global Cardiology Radiopharmaceuticals Market Forecast by Type (2024-2029)

5 Market Size Segment by Application
    5.1 Global Cardiology Radiopharmaceuticals Consumption Value Market Share by Application (2018-2023)
    5.2 Global Cardiology Radiopharmaceuticals Market Forecast by Application (2024-2029)

6 North America
    6.1 North America Cardiology Radiopharmaceuticals Consumption Value by Type (2018-2029)
    6.2 North America Cardiology Radiopharmaceuticals Consumption Value by Application (2018-2029)
    6.3 North America Cardiology Radiopharmaceuticals Market Size by Country
        6.3.1 North America Cardiology Radiopharmaceuticals Consumption Value by Country (2018-2029)
        6.3.2 United States Cardiology Radiopharmaceuticals Market Size and Forecast (2018-2029)
        6.3.3 Canada Cardiology Radiopharmaceuticals Market Size and Forecast (2018-2029)
        6.3.4 Mexico Cardiology Radiopharmaceuticals Market Size and Forecast (2018-2029)

7 Europe
    7.1 Europe Cardiology Radiopharmaceuticals Consumption Value by Type (2018-2029)
    7.2 Europe Cardiology Radiopharmaceuticals Consumption Value by Application (2018-2029)
    7.3 Europe Cardiology Radiopharmaceuticals Market Size by Country
        7.3.1 Europe Cardiology Radiopharmaceuticals Consumption Value by Country (2018-2029)
        7.3.2 Germany Cardiology Radiopharmaceuticals Market Size and Forecast (2018-2029)
        7.3.3 France Cardiology Radiopharmaceuticals Market Size and Forecast (2018-2029)
        7.3.4 United Kingdom Cardiology Radiopharmaceuticals Market Size and Forecast (2018-2029)
        7.3.5 Russia Cardiology Radiopharmaceuticals Market Size and Forecast (2018-2029)
        7.3.6 Italy Cardiology Radiopharmaceuticals Market Size and Forecast (2018-2029)

8 Asia-Pacific
    8.1 Asia-Pacific Cardiology Radiopharmaceuticals Consumption Value by Type (2018-2029)
    8.2 Asia-Pacific Cardiology Radiopharmaceuticals Consumption Value by Application (2018-2029)
    8.3 Asia-Pacific Cardiology Radiopharmaceuticals Market Size by Region
        8.3.1 Asia-Pacific Cardiology Radiopharmaceuticals Consumption Value by Region (2018-2029)
        8.3.2 China Cardiology Radiopharmaceuticals Market Size and Forecast (2018-2029)
        8.3.3 Japan Cardiology Radiopharmaceuticals Market Size and Forecast (2018-2029)
        8.3.4 South Korea Cardiology Radiopharmaceuticals Market Size and Forecast (2018-2029)
        8.3.5 India Cardiology Radiopharmaceuticals Market Size and Forecast (2018-2029)
        8.3.6 Southeast Asia Cardiology Radiopharmaceuticals Market Size and Forecast (2018-2029)
        8.3.7 Australia Cardiology Radiopharmaceuticals Market Size and Forecast (2018-2029)

9 South America
    9.1 South America Cardiology Radiopharmaceuticals Consumption Value by Type (2018-2029)
    9.2 South America Cardiology Radiopharmaceuticals Consumption Value by Application (2018-2029)
    9.3 South America Cardiology Radiopharmaceuticals Market Size by Country
        9.3.1 South America Cardiology Radiopharmaceuticals Consumption Value by Country (2018-2029)
        9.3.2 Brazil Cardiology Radiopharmaceuticals Market Size and Forecast (2018-2029)
        9.3.3 Argentina Cardiology Radiopharmaceuticals Market Size and Forecast (2018-2029)

10 Middle East & Africa
    10.1 Middle East & Africa Cardiology Radiopharmaceuticals Consumption Value by Type (2018-2029)
    10.2 Middle East & Africa Cardiology Radiopharmaceuticals Consumption Value by Application (2018-2029)
    10.3 Middle East & Africa Cardiology Radiopharmaceuticals Market Size by Country
        10.3.1 Middle East & Africa Cardiology Radiopharmaceuticals Consumption Value by Country (2018-2029)
        10.3.2 Turkey Cardiology Radiopharmaceuticals Market Size and Forecast (2018-2029)
        10.3.3 Saudi Arabia Cardiology Radiopharmaceuticals Market Size and Forecast (2018-2029)
        10.3.4 UAE Cardiology Radiopharmaceuticals Market Size and Forecast (2018-2029)

11 Market Dynamics
    11.1 Cardiology Radiopharmaceuticals Market Drivers
    11.2 Cardiology Radiopharmaceuticals Market Restraints
    11.3 Cardiology Radiopharmaceuticals Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry
    11.5 Influence of COVID-19 and Russia-Ukraine War
        11.5.1 Influence of COVID-19
        11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis
    12.1 Cardiology Radiopharmaceuticals Industry Chain
    12.2 Cardiology Radiopharmaceuticals Upstream Analysis
    12.3 Cardiology Radiopharmaceuticals Midstream Analysis
    12.4 Cardiology Radiopharmaceuticals Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Cardiology Radiopharmaceuticals Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 2. Global Cardiology Radiopharmaceuticals Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 3. Global Cardiology Radiopharmaceuticals Consumption Value by Region (2018-2023) & (USD Million)
    Table 4. Global Cardiology Radiopharmaceuticals Consumption Value by Region (2024-2029) & (USD Million)
    Table 5. GE Healthcare Company Information, Head Office, and Major Competitors
    Table 6. GE Healthcare Major Business
    Table 7. GE Healthcare Cardiology Radiopharmaceuticals Product and Solutions
    Table 8. GE Healthcare Cardiology Radiopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 9. GE Healthcare Recent Developments and Future Plans
    Table 10. Cardinal Health Company Information, Head Office, and Major Competitors
    Table 11. Cardinal Health Major Business
    Table 12. Cardinal Health Cardiology Radiopharmaceuticals Product and Solutions
    Table 13. Cardinal Health Cardiology Radiopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 14. Cardinal Health Recent Developments and Future Plans
    Table 15. Curium Pharma Company Information, Head Office, and Major Competitors
    Table 16. Curium Pharma Major Business
    Table 17. Curium Pharma Cardiology Radiopharmaceuticals Product and Solutions
    Table 18. Curium Pharma Cardiology Radiopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 19. Curium Pharma Recent Developments and Future Plans
    Table 20. Lantheus Medical Imaging, Inc. Company Information, Head Office, and Major Competitors
    Table 21. Lantheus Medical Imaging, Inc. Major Business
    Table 22. Lantheus Medical Imaging, Inc. Cardiology Radiopharmaceuticals Product and Solutions
    Table 23. Lantheus Medical Imaging, Inc. Cardiology Radiopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 24. Lantheus Medical Imaging, Inc. Recent Developments and Future Plans
    Table 25. Eczacıbaşı Monrol Nuclear Products Company Information, Head Office, and Major Competitors
    Table 26. Eczacıbaşı Monrol Nuclear Products Major Business
    Table 27. Eczacıbaşı Monrol Nuclear Products Cardiology Radiopharmaceuticals Product and Solutions
    Table 28. Eczacıbaşı Monrol Nuclear Products Cardiology Radiopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 29. Eczacıbaşı Monrol Nuclear Products Recent Developments and Future Plans
    Table 30. Novartis International AG Company Information, Head Office, and Major Competitors
    Table 31. Novartis International AG Major Business
    Table 32. Novartis International AG Cardiology Radiopharmaceuticals Product and Solutions
    Table 33. Novartis International AG Cardiology Radiopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 34. Novartis International AG Recent Developments and Future Plans
    Table 35. Siemens Company Information, Head Office, and Major Competitors
    Table 36. Siemens Major Business
    Table 37. Siemens Cardiology Radiopharmaceuticals Product and Solutions
    Table 38. Siemens Cardiology Radiopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 39. Siemens Recent Developments and Future Plans
    Table 40. China Isotope & Radiation Company Information, Head Office, and Major Competitors
    Table 41. China Isotope & Radiation Major Business
    Table 42. China Isotope & Radiation Cardiology Radiopharmaceuticals Product and Solutions
    Table 43. China Isotope & Radiation Cardiology Radiopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 44. China Isotope & Radiation Recent Developments and Future Plans
    Table 45. Yantai Dongcheng Pharmaceutical Company Information, Head Office, and Major Competitors
    Table 46. Yantai Dongcheng Pharmaceutical Major Business
    Table 47. Yantai Dongcheng Pharmaceutical Cardiology Radiopharmaceuticals Product and Solutions
    Table 48. Yantai Dongcheng Pharmaceutical Cardiology Radiopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 49. Yantai Dongcheng Pharmaceutical Recent Developments and Future Plans
    Table 50. Jubilant Life Sciences Company Information, Head Office, and Major Competitors
    Table 51. Jubilant Life Sciences Major Business
    Table 52. Jubilant Life Sciences Cardiology Radiopharmaceuticals Product and Solutions
    Table 53. Jubilant Life Sciences Cardiology Radiopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 54. Jubilant Life Sciences Recent Developments and Future Plans
    Table 55. Bracco Company Information, Head Office, and Major Competitors
    Table 56. Bracco Major Business
    Table 57. Bracco Cardiology Radiopharmaceuticals Product and Solutions
    Table 58. Bracco Cardiology Radiopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 59. Bracco Recent Developments and Future Plans
    Table 60. Global Cardiology Radiopharmaceuticals Revenue (USD Million) by Players (2018-2023)
    Table 61. Global Cardiology Radiopharmaceuticals Revenue Share by Players (2018-2023)
    Table 62. Breakdown of Cardiology Radiopharmaceuticals by Company Type (Tier 1, Tier 2, and Tier 3)
    Table 63. Market Position of Players in Cardiology Radiopharmaceuticals, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
    Table 64. Head Office of Key Cardiology Radiopharmaceuticals Players
    Table 65. Cardiology Radiopharmaceuticals Market: Company Product Type Footprint
    Table 66. Cardiology Radiopharmaceuticals Market: Company Product Application Footprint
    Table 67. Cardiology Radiopharmaceuticals New Market Entrants and Barriers to Market Entry
    Table 68. Cardiology Radiopharmaceuticals Mergers, Acquisition, Agreements, and Collaborations
    Table 69. Global Cardiology Radiopharmaceuticals Consumption Value (USD Million) by Type (2018-2023)
    Table 70. Global Cardiology Radiopharmaceuticals Consumption Value Share by Type (2018-2023)
    Table 71. Global Cardiology Radiopharmaceuticals Consumption Value Forecast by Type (2024-2029)
    Table 72. Global Cardiology Radiopharmaceuticals Consumption Value by Application (2018-2023)
    Table 73. Global Cardiology Radiopharmaceuticals Consumption Value Forecast by Application (2024-2029)
    Table 74. North America Cardiology Radiopharmaceuticals Consumption Value by Type (2018-2023) & (USD Million)
    Table 75. North America Cardiology Radiopharmaceuticals Consumption Value by Type (2024-2029) & (USD Million)
    Table 76. North America Cardiology Radiopharmaceuticals Consumption Value by Application (2018-2023) & (USD Million)
    Table 77. North America Cardiology Radiopharmaceuticals Consumption Value by Application (2024-2029) & (USD Million)
    Table 78. North America Cardiology Radiopharmaceuticals Consumption Value by Country (2018-2023) & (USD Million)
    Table 79. North America Cardiology Radiopharmaceuticals Consumption Value by Country (2024-2029) & (USD Million)
    Table 80. Europe Cardiology Radiopharmaceuticals Consumption Value by Type (2018-2023) & (USD Million)
    Table 81. Europe Cardiology Radiopharmaceuticals Consumption Value by Type (2024-2029) & (USD Million)
    Table 82. Europe Cardiology Radiopharmaceuticals Consumption Value by Application (2018-2023) & (USD Million)
    Table 83. Europe Cardiology Radiopharmaceuticals Consumption Value by Application (2024-2029) & (USD Million)
    Table 84. Europe Cardiology Radiopharmaceuticals Consumption Value by Country (2018-2023) & (USD Million)
    Table 85. Europe Cardiology Radiopharmaceuticals Consumption Value by Country (2024-2029) & (USD Million)
    Table 86. Asia-Pacific Cardiology Radiopharmaceuticals Consumption Value by Type (2018-2023) & (USD Million)
    Table 87. Asia-Pacific Cardiology Radiopharmaceuticals Consumption Value by Type (2024-2029) & (USD Million)
    Table 88. Asia-Pacific Cardiology Radiopharmaceuticals Consumption Value by Application (2018-2023) & (USD Million)
    Table 89. Asia-Pacific Cardiology Radiopharmaceuticals Consumption Value by Application (2024-2029) & (USD Million)
    Table 90. Asia-Pacific Cardiology Radiopharmaceuticals Consumption Value by Region (2018-2023) & (USD Million)
    Table 91. Asia-Pacific Cardiology Radiopharmaceuticals Consumption Value by Region (2024-2029) & (USD Million)
    Table 92. South America Cardiology Radiopharmaceuticals Consumption Value by Type (2018-2023) & (USD Million)
    Table 93. South America Cardiology Radiopharmaceuticals Consumption Value by Type (2024-2029) & (USD Million)
    Table 94. South America Cardiology Radiopharmaceuticals Consumption Value by Application (2018-2023) & (USD Million)
    Table 95. South America Cardiology Radiopharmaceuticals Consumption Value by Application (2024-2029) & (USD Million)
    Table 96. South America Cardiology Radiopharmaceuticals Consumption Value by Country (2018-2023) & (USD Million)
    Table 97. South America Cardiology Radiopharmaceuticals Consumption Value by Country (2024-2029) & (USD Million)
    Table 98. Middle East & Africa Cardiology Radiopharmaceuticals Consumption Value by Type (2018-2023) & (USD Million)
    Table 99. Middle East & Africa Cardiology Radiopharmaceuticals Consumption Value by Type (2024-2029) & (USD Million)
    Table 100. Middle East & Africa Cardiology Radiopharmaceuticals Consumption Value by Application (2018-2023) & (USD Million)
    Table 101. Middle East & Africa Cardiology Radiopharmaceuticals Consumption Value by Application (2024-2029) & (USD Million)
    Table 102. Middle East & Africa Cardiology Radiopharmaceuticals Consumption Value by Country (2018-2023) & (USD Million)
    Table 103. Middle East & Africa Cardiology Radiopharmaceuticals Consumption Value by Country (2024-2029) & (USD Million)
    Table 104. Cardiology Radiopharmaceuticals Raw Material
    Table 105. Key Suppliers of Cardiology Radiopharmaceuticals Raw Materials
List of Figures
    Figure 1. Cardiology Radiopharmaceuticals Picture
    Figure 2. Global Cardiology Radiopharmaceuticals Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 3. Global Cardiology Radiopharmaceuticals Consumption Value Market Share by Type in 2022
    Figure 4. Technetium-99
    Figure 5. Fluorine-18
    Figure 6. Gallium-67
    Figure 7. Others
    Figure 8. Global Cardiology Radiopharmaceuticals Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 9. Cardiology Radiopharmaceuticals Consumption Value Market Share by Application in 2022
    Figure 10. Therapeutic Use Picture
    Figure 11. Diagnostic Use Picture
    Figure 12. Global Cardiology Radiopharmaceuticals Consumption Value, (USD Million): 2018 & 2022 & 2029
    Figure 13. Global Cardiology Radiopharmaceuticals Consumption Value and Forecast (2018-2029) & (USD Million)
    Figure 14. Global Market Cardiology Radiopharmaceuticals Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
    Figure 15. Global Cardiology Radiopharmaceuticals Consumption Value Market Share by Region (2018-2029)
    Figure 16. Global Cardiology Radiopharmaceuticals Consumption Value Market Share by Region in 2022
    Figure 17. North America Cardiology Radiopharmaceuticals Consumption Value (2018-2029) & (USD Million)
    Figure 18. Europe Cardiology Radiopharmaceuticals Consumption Value (2018-2029) & (USD Million)
    Figure 19. Asia-Pacific Cardiology Radiopharmaceuticals Consumption Value (2018-2029) & (USD Million)
    Figure 20. South America Cardiology Radiopharmaceuticals Consumption Value (2018-2029) & (USD Million)
    Figure 21. Middle East and Africa Cardiology Radiopharmaceuticals Consumption Value (2018-2029) & (USD Million)
    Figure 22. Global Cardiology Radiopharmaceuticals Revenue Share by Players in 2022
    Figure 23. Cardiology Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
    Figure 24. Global Top 3 Players Cardiology Radiopharmaceuticals Market Share in 2022
    Figure 25. Global Top 6 Players Cardiology Radiopharmaceuticals Market Share in 2022
    Figure 26. Global Cardiology Radiopharmaceuticals Consumption Value Share by Type (2018-2023)
    Figure 27. Global Cardiology Radiopharmaceuticals Market Share Forecast by Type (2024-2029)
    Figure 28. Global Cardiology Radiopharmaceuticals Consumption Value Share by Application (2018-2023)
    Figure 29. Global Cardiology Radiopharmaceuticals Market Share Forecast by Application (2024-2029)
    Figure 30. North America Cardiology Radiopharmaceuticals Consumption Value Market Share by Type (2018-2029)
    Figure 31. North America Cardiology Radiopharmaceuticals Consumption Value Market Share by Application (2018-2029)
    Figure 32. North America Cardiology Radiopharmaceuticals Consumption Value Market Share by Country (2018-2029)
    Figure 33. United States Cardiology Radiopharmaceuticals Consumption Value (2018-2029) & (USD Million)
    Figure 34. Canada Cardiology Radiopharmaceuticals Consumption Value (2018-2029) & (USD Million)
    Figure 35. Mexico Cardiology Radiopharmaceuticals Consumption Value (2018-2029) & (USD Million)
    Figure 36. Europe Cardiology Radiopharmaceuticals Consumption Value Market Share by Type (2018-2029)
    Figure 37. Europe Cardiology Radiopharmaceuticals Consumption Value Market Share by Application (2018-2029)
    Figure 38. Europe Cardiology Radiopharmaceuticals Consumption Value Market Share by Country (2018-2029)
    Figure 39. Germany Cardiology Radiopharmaceuticals Consumption Value (2018-2029) & (USD Million)
    Figure 40. France Cardiology Radiopharmaceuticals Consumption Value (2018-2029) & (USD Million)
    Figure 41. United Kingdom Cardiology Radiopharmaceuticals Consumption Value (2018-2029) & (USD Million)
    Figure 42. Russia Cardiology Radiopharmaceuticals Consumption Value (2018-2029) & (USD Million)
    Figure 43. Italy Cardiology Radiopharmaceuticals Consumption Value (2018-2029) & (USD Million)
    Figure 44. Asia-Pacific Cardiology Radiopharmaceuticals Consumption Value Market Share by Type (2018-2029)
    Figure 45. Asia-Pacific Cardiology Radiopharmaceuticals Consumption Value Market Share by Application (2018-2029)
    Figure 46. Asia-Pacific Cardiology Radiopharmaceuticals Consumption Value Market Share by Region (2018-2029)
    Figure 47. China Cardiology Radiopharmaceuticals Consumption Value (2018-2029) & (USD Million)
    Figure 48. Japan Cardiology Radiopharmaceuticals Consumption Value (2018-2029) & (USD Million)
    Figure 49. South Korea Cardiology Radiopharmaceuticals Consumption Value (2018-2029) & (USD Million)
    Figure 50. India Cardiology Radiopharmaceuticals Consumption Value (2018-2029) & (USD Million)
    Figure 51. Southeast Asia Cardiology Radiopharmaceuticals Consumption Value (2018-2029) & (USD Million)
    Figure 52. Australia Cardiology Radiopharmaceuticals Consumption Value (2018-2029) & (USD Million)
    Figure 53. South America Cardiology Radiopharmaceuticals Consumption Value Market Share by Type (2018-2029)
    Figure 54. South America Cardiology Radiopharmaceuticals Consumption Value Market Share by Application (2018-2029)
    Figure 55. South America Cardiology Radiopharmaceuticals Consumption Value Market Share by Country (2018-2029)
    Figure 56. Brazil Cardiology Radiopharmaceuticals Consumption Value (2018-2029) & (USD Million)
    Figure 57. Argentina Cardiology Radiopharmaceuticals Consumption Value (2018-2029) & (USD Million)
    Figure 58. Middle East and Africa Cardiology Radiopharmaceuticals Consumption Value Market Share by Type (2018-2029)
    Figure 59. Middle East and Africa Cardiology Radiopharmaceuticals Consumption Value Market Share by Application (2018-2029)
    Figure 60. Middle East and Africa Cardiology Radiopharmaceuticals Consumption Value Market Share by Country (2018-2029)
    Figure 61. Turkey Cardiology Radiopharmaceuticals Consumption Value (2018-2029) & (USD Million)
    Figure 62. Saudi Arabia Cardiology Radiopharmaceuticals Consumption Value (2018-2029) & (USD Million)
    Figure 63. UAE Cardiology Radiopharmaceuticals Consumption Value (2018-2029) & (USD Million)
    Figure 64. Cardiology Radiopharmaceuticals Market Drivers
    Figure 65. Cardiology Radiopharmaceuticals Market Restraints
    Figure 66. Cardiology Radiopharmaceuticals Market Trends
    Figure 67. Porters Five Forces Analysis
    Figure 68. Manufacturing Cost Structure Analysis of Cardiology Radiopharmaceuticals in 2022
    Figure 69. Manufacturing Process Analysis of Cardiology Radiopharmaceuticals
    Figure 70. Cardiology Radiopharmaceuticals Industrial Chain
    Figure 71. Methodology
    Figure 72. Research Process and Data Source

Companies Mentioned

GE Healthcare
Cardinal Health
Curium Pharma
Lantheus Medical Imaging, Inc.
Eczacıbaşı Monrol Nuclear Products
Novartis International AG
Siemens
China Isotope & Radiation
Yantai Dongcheng Pharmaceutical
Jubilant Life Sciences
Bracco